Global Cholera vaccines Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2017 to 2025

  • ID: 4431862
  • Report
  • Region: Global
  • Acute Market Reports
1 of 4

FEATURED COMPANIES

  • Astellas Pharma, Inc.
  • Eubiologics
  • PaxVax
  • Sonofi
  • Valneva SE
  • MORE
Cholera vaccines Market - Growth, Future Prospects and Competitive Analysis, 2017 - 2025 the global cholera vaccines market was valued at US$ 51.3 Mn in 2016, and is expected to reach US$ 234.5 Mn by 2025, expanding at a CAGR of 15.8% from 2017 to 2025.

Market Insights

According to World Health Organization (WHO), there are roughly 1.3 to 4.0 million cholera cases, and 21,000 to 143,000 deaths worldwide each year due to cholera. The burden of cholera remains high globally, particularly in developing countries in Asia and Africa. Cholera prevention and treatment protocols are well established; government initiatives in immunization program is prime factor driving the market growth of cholera vaccines globally. For the purpose of study, the cholera vaccines market is segmented on the basis of product type such as Dukoral, Shanchol, Vaxchora and others; it is estimated that Vaxchora would grow significantly during forecast period because Vaxchora is the only vaccine available in the United States for protection against cholera and the only single dose vaccine for cholera currently licensed anywhere in the world. Centers for Disease Control and Prevention’s (CDC) and Advisory Committee on Immunization Practices (ACIP) recommended the use of Vaxchora in 18 to 64 years of age adults.

North America is expected to grow significantly during forecast period due to government initiatives in treatment and awareness program, higher cost of product and extensive research and development activities are driving the market growth in North America. Centers for Disease Control and Prevention (CDC) recommendation for travelers to cholera-affected regions would assist the market growth in United States. However, Asia Pacific currently dominating the market due to higher number of affected population, rising healthcare awareness and government initiatives in immunization program are fueling the market growth in Asia Pacific.

Market Competition Assessment

The cholera vaccines market is observed to be highly competitive and comprises large number of players. However, the market is currently dominated by few players such as Astellas Pharma, Inc., PaxVax, Sanofi, Valneva, Eubiologics and other.

Key Market Movements:
  • Factors such as increasing prevalence of cholera in Asia and Africa, extensive government initiative in immunization program, research and development activities in development of vaccines are expected to drive the growth of cholera vaccines market globally.
  • Vendors in the market are focusing on innovation and technological advances in developing ideal and cost effective cholera vaccine, this would further assist the growth of cholera vaccines market globally.
  • However, some factors such as lower healthcare awareness in some countries, may negatively impacting the growth of cholera vaccines market globally.
READ MORE
Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • Astellas Pharma, Inc.
  • Eubiologics
  • PaxVax
  • Sonofi
  • Valneva SE
  • MORE
Chapter 1 Preface
1.1 Report Description
1.1.1 Purpose of the Report
1.1.2 Target Audience
1.1.3 USP and Key Offerings
1.2 Research Scope
1.3 Research Methodology
1.3.1 Phase I - Secondary Research
1.3.2 Phase II - Primary Research
1.3.3 Phase III - Expert Panel Review
1.3.4 Assumptions

Chapter 2 Executive Summary
2.1 Global Cholera Vaccines Market Portraiture
2.2 Global Cholera Vaccines Market (US$ Mn), by Product Type, 2016
2.3 Global Cholera Vaccines Market Share (Value %), by Geography, 2016

Chapter 3 Global Cholera Vaccines Market: Dynamics and Competitive Outlook
3.1 Market Overview
3.2 Market Drivers
3.2.1 Increasing Travellers from developed to underdeveloped countries
3.2.2 Growing Initiatives by World Healthcare Organization to control Cholera
3.3 Challenges
3.3.1 Side effects related to the vaccines
3.4 Future Prospects
3.4.1 Government Recommendation of Vaccination before travelling to Cholera Affected Regions
3.5 Attractive Investment Proposition
3.6 Competitive Analysis of Key Players in Cholera Vaccines Market

Chapter 4 Global Cholera Vaccines Market Analysis, by Product
4.1 Introduction
4.2 Attractive Investment Proposition: Global Cholera Vaccines Market, by Product, 2016 Vs 2025 (Value %)
4.3 Dukoral
4.4 Shanchol
4.5 Vaxchora
4.6 Others

Chapter 5 Global Cholera Vaccines Market, By Geography
5.1 Preface
5.2 Global Cholera Vaccines Market Share Analysis, by Geography, 2016 vs 2025 (Value %)
5.3 North America (U.S. & Canada)
5.4 Europe (U.K., Germany & Rest of Europe)
5.5 Asia Pacific (China, Japan, and Rest of APAC)
5.6 Latin America
5.7 Middle East and Africa

Chapter 6 Company Profiles
6.1 Astellas Pharma, Inc.
6.2 Sonofi
6.3 PaxVax
6.4 Valneva SE
6.5 Eubiologics

List of Figures
Fig. 1 Cholera Vaccines Market: Research Methodology
Fig. 2 Global Cholera Vaccines Market (US$ Mn), by Product Type, 2016
Fig. 3 Global Cholera Vaccines Market Share (Value %), by Geography, 2016
Fig. 4 Attractive Investment Proposition
Fig. 5 Competitive Analysis of Key Players in Cholera Vaccines Market
Fig. 6 Global Cholera Vaccines Market Share Analysis, by Product, 2016 vs 2025 (Value %)
Fig. 7 Global Dukoral Cholera Vaccines Market, 2015 - 2025 (US$ Mn)
Fig. 8 Global Shanchol Cholera Vaccines Market, 2015 - 2025 (US$ Mn)
Fig. 9 Global Vaxchora Cholera Vaccines Market, 2015 - 2025 (US$ Mn)
Fig. 10 Global Other Cholera Vaccines Market, 2015 - 2025 (US$ Mn)
Fig. 11 Global Cholera Vaccines Market Share Analysis, by Geography, 2016 vs 2025 (Value %)
Fig. 12 U.S. Cholera Vaccines Market, 2015 - 2025 (US$ Mn)
Fig. 13 Canada Cholera Vaccines Market, 2015 - 2025 (US$ Mn)
Fig. 14 U.K. Cholera Vaccines Market, 2015 - 2025 (US$ Mn)
Fig. 15 Germany Cholera Vaccines Market, 2015 - 2025 (US$ Mn)
Fig. 16 Rest of Europe Cholera Vaccines Market, 2015 - 2025 (US$ Mn)
Fig. 17 China Cholera Vaccines Market, 2015 - 2025 (US$ Mn)
Fig. 18 Japan Cholera Vaccines Market, 2015 - 2025 (US$ Mn)
Fig. 19 Rest of Asia-Pacific Cholera Vaccines Market, 2015 - 2025 (US$ Mn)
Fig. 20 Brazil Cholera Vaccines Market, 2015 - 2025 (US$ Mn)
Fig. 21 Mexico Cholera Vaccines Market, 2015 - 2025 (US$ Mn)
Fig. 22 Rest of Latin America Cholera Vaccines Market, 2015 - 2025 (US$ Mn)
Fig. 23 GCC Cholera Vaccines Market, 2015 - 2025 (US$ Mn)
Fig. 24 Rest of MEA Cholera Vaccines Market, 2015 - 2025 (US$ Mn)

List of Tables
Table 1 Global Cholera Vaccines Market, by Product, 2015-2025 (US$ Mn)
Table 2 Global Cholera Vaccines Market, by Geography, 2015 - 2025 (US$ Mn)
Table 3 North America Cholera Vaccines Market, by Country, 2015 - 2025 (US$ Mn)
Table 4 Europe Cholera Vaccines Market, by Country, 2015 - 2025 (US$ Mn)
Table 5 Asia Pacific Cholera Vaccines Market, by Country, 2015 - 2025 (US$ Mn)
Table 6 Latin America Cholera Vaccines Market, by Country, 2015 - 2025 (US$ Mn)
Table 7 Middle East & Africa Cholera Vaccines Market, by Region, 2015 - 2025 (US$ Mn)
Table 8 Astellas Pharma, Inc.: Company Snapshot (Business Description; Product Portfolio; Financial Information; Business Strategies)
Table 9 Sonofi: Company Snapshot (Business Description; Product Portfolio; Financial Information; Business Strategies)
Table 10 PaxVAx: Company Snapshot (Business Description; Product Portfolio; Financial Information; Business Strategies)
Table 11 Valneva SE: Company Snapshot (Business Description; Product Portfolio; Financial Information; Business Strategies)
Table 12 Eubiologics: Company Snapshot (Business Description; Product Portfolio; Financial Information; Business Strategies)
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
  • Astellas Pharma, Inc.
  • Sonofi
  • PaxVax
  • Valneva SE
  • Eubiologics
Note: Product cover images may vary from those shown
5 of 4
Note: Product cover images may vary from those shown
Adroll
adroll